FDA Hits Connecticut Sterile Drugmaker for Mold Contamination

Drug Industry Daily
A A
The FDA cited Johnson Memorial Cancer Center’s Enfield, Connecticut sterile drug manufacturing facility after investigators found sterility problems, airflow issues and mold contamination during an Oct. 1 to Oct. 19 inspection.

To View This Article:

Login

Subscribe To Drug Industry Daily